BioSpecifics Technologies appoints Max Link to its Board of Directors
– USA, NY – BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced the appointment of Max Link, Ph.D.…